Climb Bio, Inc. financial data

Symbol
CLYM on Nasdaq
Location
Wellesley Hills, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1875% % -62%
Debt-to-equity 3% % 62%
Return On Equity -26% % 37%
Return On Assets -26% % 38%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68,184,435 shares 1.4%
Common Stock, Shares, Outstanding 68,184,435 shares 1.4%
Entity Public Float $195,900,000 USD 1384%
Common Stock, Value, Issued $7,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 68,003,248 shares 1.5%
Weighted Average Number of Shares Outstanding, Diluted 68,003,248 shares 1.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $38,774,000 USD 237%
General and Administrative Expense $20,564,000 USD 57%
Operating Income (Loss) $59,498,000 USD 22%
Nonoperating Income (Expense) $2,004,000 USD -29%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $50,751,000 USD 27%
Earnings Per Share, Basic 0 USD/shares 92%
Earnings Per Share, Diluted 0 USD/shares 92%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $25,803,000 USD -82%
Marketable Securities, Current $61,098,000 USD 30%
Assets, Current $90,964,000 USD -54%
Property, Plant and Equipment, Net $318,000 USD
Operating Lease, Right-of-Use Asset $562,000 USD 4583%
Other Assets, Noncurrent $1,530,000 USD
Assets $182,304,000 USD -18%
Accounts Payable, Current $477,000 USD 64%
Employee-related Liabilities, Current $1,540,000 USD
Accrued Liabilities, Current $6,104,000 USD 131%
Liabilities, Current $4,949,000 USD 45%
Operating Lease, Liability, Noncurrent $352,000 USD
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $5,301,000 USD 55%
Accumulated Other Comprehensive Income (Loss), Net of Tax $469,000 USD 133%
Retained Earnings (Accumulated Deficit) $272,211,000 USD -23%
Stockholders' Equity Attributable to Parent $177,003,000 USD -19%
Liabilities and Equity $182,304,000 USD -18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $15,434,000 USD -748%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $42,751,000 USD -411%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 68,184,435 shares 1.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $58,209,000 USD -588%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $25,803,000 USD -82%
Deferred Tax Assets, Valuation Allowance $28,492,000 USD 37%
Deferred Tax Assets, Gross $28,630,000 USD 37%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $50,483,000 USD 27%
Operating Lease, Liability, Current $228,000 USD 293%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 13%
Deferred Tax Assets, Operating Loss Carryforwards $22,725,000 USD 33%
Share-based Payment Arrangement, Expense $8,669,000 USD 70%